EP3898679 - POLYPEPTIDES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 24.09.2021 Database last updated on 31.08.2024 | |
Former | The international publication has been made Status updated on 02.07.2020 | ||
Former | unknown Status updated on 08.01.2020 | Most recent event Tooltip | 19.12.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund / SE | [2021/43] | Inventor(s) | 01 /
SÄLL, Anna Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund / SE | 02 /
ELLMARK, Peter Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund / SE | 03 /
DERONIC, Adnan Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund / SE | 04 /
CARLSSON, Fredrika Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund / SE | 05 /
HÄGERBRAND, Karin Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund / SE | 06 /
VON SCHANTZ, Laura Alligator Bioscience AB Medicon Village Scheelevägen 2 223 81 Lund / SE | [2021/43] | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
Former [2021/43] | Potter Clarkson The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | Application number, filing date | 19828547.0 | 17.12.2019 | [2021/43] | WO2019EP85786 | Priority number, date | GB20180020556 | 17.12.2018 Original published format: GB 201820556 | GB20190005467 | 17.04.2019 Original published format: GB 201905467 | GB20190010016 | 12.07.2019 Original published format: GB 201910016 | [2021/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2020127374 | Date: | 25.06.2020 | Language: | EN | [2020/26] | Type: | A2 Application without search report | No.: | EP3898679 | Date: | 27.10.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.06.2020 takes the place of the publication of the European patent application. | [2021/43] | Search report(s) | International search report - published on: | EP | 29.10.2020 | Classification | IPC: | C07K16/28, C07K16/30, A61P35/00, A61K39/00, C07K16/32 | [2021/43] | CPC: |
C07K16/2878 (EP,CN,US);
C07K16/3092 (US);
A61K39/3955 (US);
A61K45/06 (US);
A61P35/00 (CN,US);
A61P35/02 (CN);
C07K16/2803 (US);
C07K16/2851 (EP,US);
C07K16/2863 (US);
C07K16/2866 (US);
C07K16/2887 (US);
C07K16/30 (EP,CN,US);
C07K16/3007 (US);
C07K16/3015 (US);
C07K16/32 (EP);
G01N33/56966 (CN);
G01N33/57488 (CN);
G01N33/57492 (US);
A61K2039/505 (EP,CN,US);
C07K2317/21 (US);
C07K2317/31 (EP,CN,US);
C07K2317/55 (US);
C07K2317/56 (CN,US);
C07K2317/565 (CN);
C07K2317/569 (CN,US);
C07K2317/622 (CN,US);
C07K2317/624 (CN);
C07K2317/73 (CN);
C07K2317/732 (CN);
C07K2317/734 (CN);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/43] | Title | German: | POLYPEPTIDE | [2021/43] | English: | POLYPEPTIDES | [2021/43] | French: | POLYPEPTIDES | [2021/43] | Entry into regional phase | 13.07.2021 | National basic fee paid | 13.07.2021 | Designation fee(s) paid | 13.07.2021 | Examination fee paid | Examination procedure | 13.07.2021 | Examination requested [2021/43] | 13.07.2021 | Date on which the examining division has become responsible | 01.02.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 08.12.2021 | Renewal fee patent year 03 | 13.12.2022 | Renewal fee patent year 04 | 19.12.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]US2018194862 (AKAMATSU YOSHIKO [US], et al) [X] 1-3,79,80,84,86,90-92,104-109 * the whole document * [I] 4-68,81-83,85,87-89,93-103; | [XP]WO2019093342 (KYOWA HAKKO KIRIN CO LTD [JP]) [XP] 1-68,79-109 * the whole document * | [XI] - BUSHRA HUSAIN ET AL, "Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies", BIODRUGS, NZ, (20180821), vol. 32, no. 5, doi:10.1007/s40259-018-0299-9, ISSN 1173-8804, pages 441 - 464, XP055678494 [X] 1-3,79,80,84,86,90-92,104-109 * the whole document * [I] 4-68,81-83,85,87-89,93-103 DOI: http://dx.doi.org/10.1007/s40259-018-0299-9 | [XI] - Anonymous, "AbbVie R&D Day Forward-Looking Statements and Non-GAAP Financial Information", (20160101), URL: https://investors.abbvie.com/static-files/4c774749-25a8-4c8d-939d-3a3cdc45c8d6, (20200322), XP055678496 [X] 1-3,79,80,84,86,90-92,104-109 * the whole document * [I] 4-68,81-83,85,87-89,93-103 | [XI] - E Dahlen ET AL, "Therapeutic Advances in Vaccines and Immunotherapy Bispecific antibodies in cancer immunotherapy", Therapeutic Advances in Vaccines and Immunotherapy, doi:10.1177/2515135518763280Therapeutic, (20180301), pages 3 - 17, URL: https://journals.sagepub.com/doi/pdf/10.1177/2515135518763280, (20200322), XP055678495 [X] 1-3,79,80,84,86,90-92,104-109 * the whole document * [I] 4-68,81-83,85,87-89,93-103 DOI: http://dx.doi.org/10.1177/2515135518763280Therapeutic | by applicant | US2010021483 | US4816567 | US2012251531 | US7557190 | US6235883 | US4235871 | US5851451 | EP0213303 | - NYGREN, FEBS J, (20080000), vol. 275, pages 2668 - 2676 | - Innovations Pharmac. Technol., (20060000), pages 27 - 30 | - Meth. Mol. Biol., (20070000), vol. 352, pages 95 - 109 | - Drug Discovery Today, (20050000), vol. 10, pages 23 - 33 | - Nat. Biotechnol., (20040000), vol. 22, pages 575 - 582 | - Nat. Biotechnol., (20050000), vol. 23, pages 1556 - 1561 | - FEBS J, (20070000), vol. 274, pages 86 - 95 | - Expert. Opin. Biol. Ther., (20050000), vol. 5, pages 783 - 797 | - J. Pharmacol. Exp. Ther., (20060000), vol. 318, pages 803 - 809 | - Trends. Biotechnol., (20050000), vol. 23, pages 514 - 522 | - XU et al., mAbs, (20150000), vol. 7, no. 1, pages 231 - 242 | GB20180020556 |